Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Alefacept therapy beneficial in the treatment of psoriasis

Oct. 28, 2003

Polyphenon E (EGCg) improves preaged and damaged facial skin

Oct. 28, 2003

Topical bimosiamose studied in psoriasis and atopic dermatitis

Oct. 14, 2003

New topical antiinflammatory agents and their use described by Japan Energy

Oct. 14, 2003

Recombinant alpha1-antitrypsin enters proof-of-concept study for atopic dermatitis

Oct. 13, 2003

Successful completion of phase I trial of Tbeta4

Oct. 10, 2003

Biogen licenses rights to oral psoriasis product from Fumapharm

Oct. 6, 2003

Treatment completed in phase IIb trial of MBI-594AN for acne

Oct. 6, 2003

Positive phase III results for Actiza

Oct. 2, 2003

XMP-629 enters phase I trial for topical treatment of acne

Oct. 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...